Hudson Bay Capital Management »

Eliem Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $195k 49k 4.00
2022-03-31 $839k 100k 8.39
2021-12-31 $1.0M 100k 10.46
2021-09-30 $1.8M 100k 17.98

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Microsoft Corporation Call Option (MSFT)
Netflix Put Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Flagstar Bank National Assoc Com New (FLG)
Dollar Tree Call Option (DLTR)
Boeing Company Call Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
ADAR1 Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Dr. Jeffrey R. Jay, M.D.
Sphera Funds Management
Point72 Asset Management
Peapod Lane Capital
Millennium Management
Nan Fung Trinity
Susquehanna International
BlackRock
Renaissance Technologies

View all funds holding Eliem Therapeutics